|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||125.70 - 125.70|
|52-week range||99.21 - 128.94|
|PE ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y target est||N/A|
A Relative Strength Rating upgrade for Stryker shows improving technical performance. Will it continue?
Stryker Corporation (SYK) has successfully expanded its product portfolio over time, which aids the company to cater to evolving demands of customers.
The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers' knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.
GE Additive (NYSE: GE) and Stryker have entered a partnership agreement to support Stryker’s growth in additive manufacturing. “GE and Stryker share a similar vision and both of us understand the transformative power of additive design and manufacturing,” said Vice President and General Manager of GE Additive, Mohammad Ehteshami. “We regard Stryker as one of the most experienced practitioners of metal additive, with a range of commercialised medical products.